ACE inhibitor effects on platelet function in stages I-II hypertension.

Moser, L; Callahan, K S; Cheung, A K; Stoddard, G J; Munger, M A

Moser, L; Callahan, K S; Cheung, A K; Stoddard, G J; Munger, M A.

Affiliation

Moser L; Department of Pharmacy Practice, University of Utah Health Sciences Center, Salt Lake City 84112, U.S.A.

J Cardiovasc Pharmacol ; 30(4): 461-7, 1997 Oct.

Article in En | MEDLINE | ID: mdl-9335405

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/pharmacology; Antihypertensive Agents/pharmacology; Blood Platelets/drug effects; Hypertension/blood; Adult; Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Antihypertensive Agents/pharmacokinetics; Antihypertensive Agents/therapeutic use; Area Under Curve; Blood Platelets/physiology; Humans; Hypertension/drug therapy; Male; Middle Aged; Platelet Aggregation/drug effects; Thromboxane B2/antagonists & inhibitors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Platelets / Angiotensin-Converting Enzyme Inhibitors / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: J Cardiovasc Pharmacol Year: 1997 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links